Biotechnology is a $350 billion-a-year industry for the U.S., but until now, President Donald J. Trump has never mentioned it.
Why you should care: Trump hasn’t ever said the words “CRISPR,” “embryo editing,” “eugenics,” or “gene therapy,” either. Biologists are understandably anxious about what he thinks.
What he’s said now: “We are streamlining regulations that have blocked cutting-edge biotechnology, setting free our farmers to innovate, thrive, and to grow,” Trump told a meeting of the American Farm Bureau Federation in Nashville, Tennessee, on January 8. (He added, “Oh, are you happy you voted for me. You are so lucky that I gave you that privilege.”)
He’s pro-GMO? Sounds like it. KFC-loving Trump may have been referring to how, in November, his administration scrapped USDA rules that would have regulated plants created through gene-editing tools like CRISPR.
In an e-mail, a spokesperson for the Biotechnology Innovation Organization, the industry’s trade group, confirmed it was the first time Trump has uttered the word as president.
This startup wants to copy you into an embryo for organ harvesting
With plans to create realistic synthetic embryos, grown in jars, Renewal Bio is on a journey to the horizon of science and ethics.
The feud between a weed influencer and scientist over puking stoners
A scientist went looking for genes that cause cannabinoid hyperemesis syndrome. But a public spat with a cannabis influencer who suffers from the disease may have derailed his research.
Edits to a cholesterol gene could stop the biggest killer on earth
In a first, a patient in New Zealand has undergone gene-editing to lower their cholesterol. It could be the beginning of new era in disease prevention.
Monkeypox is in Bay Area wastewater
It showed up in Stanford’s Sewer Coronavirus Alert Network, which is the only group publishing data on monkeypox in US wastewater.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.